Screener
Praxis Precision Medicines, Inc. PRAX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s accounts payable?
- Praxis Precision Medicines, Inc. (PRAX) reported accounts payable of $23.39M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s accounts payable changed year-over-year?
- Praxis Precision Medicines, Inc.'s accounts payable decreased by 18.9% year-over-year, from $28.83M to $23.39M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s accounts payable has grown at a 43.2% compound annual growth rate (CAGR), from $4.09M to $24.63M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Praxis Precision Medicines, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude